庾杰华
YU Jiehua

• 1:广州市第十二人民医院

摘要(Abstract)：

目的探讨再生障碍性贫血患者院内感染易感因素及预防措施。方法对本院2011~2013年的再生障碍性贫血患者发生院内感染情况进行回顾性分析。结果再生障碍性贫血患者院内感染率为36.0%,极重型再生障碍性贫血患者为84.2%,感染好发部位为呼吸道,其次是口腔、胃肠、皮肤等,白细胞计数小于1.5×109/L的患者院内感染率明显高于白细胞计数大于1.5×109/L;住院时间小于30 d的患者院内感染率明显低于住院时间超过30 d的患者。结论再生障碍性贫血患者易发生院内感染,感染最常见部位为呼吸道,住院时间过长,白细胞数过低,均易增加感染机会,应加强预防措施,尽量减少院内感染,提高患者生存率。
OBJECTIVE To assess the factors in uencing the nosocomial infection in patients with aplastic anemia( AA),and investigate the preventive measures. METHODS Infection control committee records were reviewed to identify the cases between 2011 and 2013. Only the AA patient was included in the study. RESULTS A total of 189 patients with AA were identi ed. The infection rate was 36. 0%,and 84. 2% for severe ones. The commonly seen infected part was respiratory tract,then was oral cavity,gastrointestinal,skin,and so on. The infection in AA patients with WBC below 1. 5 × 109/ L was higher than those with higher WBC.Patients with long-term( > 30 d) hospitalization were more easily subjected to the infection. CONCLUSION Patients with AA are at high risk for nosocomial infection. Respiratory tract is the most commonly infected part. Long-term hospitalization and lower WBC can both increase the infection rate. To improve the survival rate,it is important to strengthen preventive measures of the infection.

关键词(KeyWords)： 再生障碍性贫血;感染;数据分析
aplastic anemia;infection;data analysis

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 庾杰华
YU Jiehua

参考文献(References)：

• [1]中华医学会血液学分会.再生障碍性贫血诊断治疗专家共识[J].中华血液学杂志,2010,31(11):96-99.
• [2]张曼昱,蒋文明.再生障碍性贫血的发病机制的研究进展[J].湖南中医药大学学报,2013,33(10):102-103.
• [3]Gkhan Metana,Hayati Demiraslana,Leyla Gül Kaynar.Factors influencing the early mortality in haematologicalmalignancy patients with nosocomial Gram negative bacilli bacteraemia:a retrospective analysis of 154 cases[J].BRAZ J INFECT DIS.2013,17(2):143-149.
• [4]秦福丽.血液病患者感染的特点与防治[J].临床经验,2009,18(8):484-485.
• [5]李广伦,秦萍.再生障碍性贫血患者院内感染分析[J].齐鲁医学杂志,2006,21(2):126-127.
• [6]刘春燕,邵宗鸿.再生障碍性贫血的免疫治疗[J].临床内科杂志,2012,29(6):365-367.